The Trump administration is launching an effort aimed at bringing clinical trials back to the United States, after years of more trials moving overseas, according to a June 22 announcement from the Department of Health and Human Services (HHS).
HHS and some of its divisions, such as the Food and Drug Administration, are involved in the new effort, dubbed Operation TrailBlazer.
